hotspot -WSS

hotspot

author：Wikipedia 2025-09-03 18:38:30 - browse：6

Warning sign illustration made of 0s and 1s. -- first opinion coverage from sTAT — Adobe

Big businesses poised to profit from the advance of artificial intelligence in health care are pushing back against newly proposed federal rules meant to increase oversight and fairness of AI tools used to help make decisions about patient care.

The opposition, which includes Google and Amazon as well as large health care providers, insurers, and medical software vendors, is focused on an attempt to put tighter guardrails around the use of AI by the Office of the National Coordinator for Health Information Technology.

The agency wants to require developers of electronic health records and other health software to provide users with details about the training and testing of predictive models that draw data from their systems, or are hosted within them. It also wants developers to assess and publicly disclose potential risks and create a way for clinicians and other users to report problems.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Alkermes shareholders re
Next article： Spinal cord stimulation reduces pain in amputees, study finds

WSS

The pink breast cancer awareness ribbon needs a redesign

Physician subsidies by hospitals soar in wake of No Surprises Act

Traditional Chinese medicine benefits explored in new JAMA study

STAT letters to the editor on burnt

Supreme Court wrestles with OxyContin maker's bankruptcy deal

CDC recommends rationing of RSV shot due to shortages

leisure time

hotspot

hotspot

Drug repurposing or repositioning? The language matters

Sanofi says it has 12 blockbusters on the way. Will investors believe it?

Medicare proposal to cover medical devices draws a mixed reaction

After sickle

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

What PEPFAR has meant on the ground in Ukraine

Apple is now the first public company to be valued at $3 trillion

Readout Newsletter: XBI biotech index, Akero Therapeutics

Guidelines to prevent youth baseball injuries need more muscle

Readout Newsletter: What happened with Sarepta's Duchenne data

focus

An exit interview with Bristol Myers Squibb CEO Giovanni Caforio

Emergency medicine has repudiated 'excited delirium.' Now what?

Medtronic CEO on promising devices for diabetes, hypertension

First Opinion Podcast: How to protect health care in times of war

FDA needs staff influx to meet gene therapy needs, Marks says

Supreme Court wrestles with OxyContin maker's bankruptcy deal

focus

knowledge

hotspot

hotspot